Atlas Trials

Dimethylfumarate (DMF) in Relapsed/Refractory CLL/SLL

Clinical trial NCT02784834 · TERMINATED

Trial details

NCT number
NCT02784834
Sponsor
Michael Choi
Status
TERMINATED
Phase
Phase 1
Study type
INTERVENTIONAL
Chronic Lymphocytic LeukemiaSmall Lymphocytic Lymphoma
Start date
2016-06-01
Primary completion
2019-02-01
Enrollment
2

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.